Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Files

Early antiviral in hemato Covid.pdf (387.08 KB)

Document type

Article

Version

Accepted version

Publication date

2023-04-13

All rights reserved

Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/206271

Current outcomes of SARS-CoV-2 Omicron variant infection in high-risk haematological patients treated early with antivirals

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

https://doi.org/10.1093/jac/dkad105

Subject

Medicaments antivírics, Medicaments dermatològics

Subject (English)

Antiviral agents, Dermatologic agents

Citation

Collections

Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Citation

AIELLO, Tommaso Francesco, et al. Current outcomes of SARS-CoV-2 Omicron variant infection in high-risk haematological patients treated early with antivirals. Journal Of Antimicrobial Chemotherapy. 2023. Vol. 78, num. 6, pags. 1454-1459. ISSN 1460-2091. [consulted: 12 of August of 2026]. Available at: https://hdl.handle.net/2445/206271

Export metadata

JSON - METS

Share record